US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Elutia

2.30

-0.0200-0.86%

Post-market: 2.300.00000.00%16:00 EDT

Volume:12.96K

Turnover:29.56K

Market Cap:93.69M

PE:-1.24

High:2.33

Open:2.26

Low:2.19

Close:2.32

Loading ...

Overview Company News Filings

Elutia Initiates EluPro™ Registry Study Designed to Generate Evidence Supporting the Use of EluPro in Real-World Clinical Practice

Elutia Confirms No Material Impact From Global Tariffs

THOMSON REUTERS

BRIEF-Elutia Inc May Offer & Sell Up To $50.0 Million Of Shares Of Class A Common Stock - SEC Filing

Elutia Inc May Offer & Sell up to $50.0 Mln of Shares of Class a Common Stock - SEC Filing

THOMSON REUTERS

Elutia to Debut EluPro™ at HRS 2025 — Experience the Difference Biology Makes

BRIEF-Elutia Announces GPO Agreement With Advantus Health Partners To Expand Access To EluPro

Elutia announces GPO agreement with Advantus Health Partners

Elutia Announces Gpo Agreement With Advantus Health Partners to Expand Access to Elupro™

THOMSON REUTERS

Press Release: Elutia Announces GPO Agreement with Advantus Health Partners to Expand Access to EluPro(TM)

BRIEF-Elutia Files For Mixed Shelf Of Up To $100 Million – SEC Filing

Elutia Inc Files for Mixed Shelf of up to $100 Mln – SEC Filing

THOMSON REUTERS

Elutia : Sales Agreement Prospectus Covering Issuance of up to $50 Mln of Class a Common Stock That May Be Issued Under Sales Agreement

THOMSON REUTERS

Elutia Price Target Maintained With a $8.00/Share by Cantor Fitzgerald

Analysts Offer Insights on Healthcare Companies: Phathom Pharmaceuticals (PHAT), Aziyo Biologics (ELUT) and IGM Biosciences (IGMS)

Q4 2024 Elutia Inc Earnings Call

Thomson Reuters StreetEvents

Elutia Inc (ELUT) Q4 2024 Earnings Call Highlights: Strategic Partnerships and Product Growth ...

Elutia Inc. Reports Strong Demand for EluPro™

Elutia Inc reports results for the quarter ended December 31 - Earnings Summary

Elutia reports Q4 EPS (26c) vs. (40c) last year

Elutia Q4 GAAP EPS $(0.26) Misses $(0.25) Estimate, Sales $5.47M Miss $5.90M Estimate

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ELUT/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ELUT","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ELUT\",,,,,undefined,":{"symbol":"ELUT","market":"US","secType":"STK","nameCN":"Elutia","latestPrice":2.3,"timestamp":1745265600000,"preClose":2.32,"halted":0,"volume":12961,"hourTrading":{"tag":"盘后","latestPrice":2.3,"preClose":2.3,"latestTime":"16:00 EDT","volume":333,"amount":765.9,"timestamp":1745265605266},"delay":0,"floatShares":19876749,"shares":40736888,"eps":-1.855759,"marketStatus":"Post-Mkt","change":-0.02,"latestTime":"04-21 19:03:29 EDT","open":2.26,"high":2.33,"low":2.19,"amount":29555.5802,"amplitude":0.060345,"askPrice":2.6,"askSize":100,"bidPrice":2,"bidSize":500,"shortable":3,"etf":0,"ttmEps":-1.855759,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1745280000000},"marketStatusCode":4,"adr":0,"listingDate":1602129600000,"exchange":"NASDAQ","adjPreClose":2.32,"postHourTrading":{"tag":"盘后","latestPrice":2.3,"preClose":2.3,"latestTime":"16:00 EDT","volume":333,"amount":765.9,"timestamp":1745265605266},"volumeRatio":0.43526},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ELUT\",,,,,undefined,":{"symbol":"ELUT","floatShares":19876749,"roa":"-38.15%","roe":"--","lyrEps":-1.855759,"volumeRatio":0.43526,"shares":40736888,"dividePrice":0,"high":2.33,"amplitude":0.060345,"preClose":2.32,"low":2.19,"week52Low":1.87,"pbRate":"-2.03","psRate":"3.84","week52High":5.24,"institutionHeld":0,"latestPrice":2.3,"committee":0.666667,"eps":-1.855759,"divideRate":0,"volume":12961,"delay":0,"ttmEps":-1.855759,"open":2.26,"prevYearClose":3.74,"prevWeekClose":2.32,"prevMonthClose":2.53,"prevQuarterClose":2.53,"fiveDayClose":2.17,"twentyDayClose":2.92,"sixtyDayClose":3.28},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ELUT\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2529806578","title":"Elutia Initiates EluPro™ Registry Study Designed to Generate Evidence Supporting the Use of EluPro in Real-World Clinical Practice","url":"https://stock-news.laohu8.com/highlight/detail?id=2529806578","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529806578?lang=en_us&edition=fundamental","pubTime":"2025-04-21 20:00","pubTimestamp":1745236800,"startTime":"0","endTime":"0","summary":"— Integration of clinical and patient-reported outcomes expected to further differentiate EluPro’s utility in cardiac implantable electronic device  procedures —。“Every innovation we pursue is driven by a commitment to improving patient care,” saidKimberly Mulligan, PhD, Vice President and General Manager of Cardiovascularat Elutia. “With EluPro, we combined trusted antibiotics with a soft, regenerative biomatrix to protect the implant, facilitate implantation, and support healing. This study will allow us to collect data on these differentiating characteristics in real-world practice.”The multi-center clinical study is a prospective, post-market study designed to evaluate the use of EluPro in standard clinical practice and its performance across a diverse population of patients undergoing CIED implantation. Data on clinical and patient-reported outcomes will be collected, which will include assessments of key complications of interest following CIED implantation - such as infection, h","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/elutia-initiates-elupro-registry-study-120000062.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","ELUT"],"gpt_icon":0},{"id":"2527393154","title":"Elutia Confirms No Material Impact From Global Tariffs","url":"https://stock-news.laohu8.com/highlight/detail?id=2527393154","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527393154?lang=en_us&edition=fundamental","pubTime":"2025-04-14 20:00","pubTimestamp":1744632004,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250414:nFWN3QR02N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ELUT","BK4139"],"gpt_icon":0},{"id":"2526646510","title":"BRIEF-Elutia Inc May Offer & Sell Up To $50.0 Million Of Shares Of Class A Common Stock - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2526646510","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526646510?lang=en_us&edition=fundamental","pubTime":"2025-04-12 04:25","pubTimestamp":1744403110,"startTime":"0","endTime":"0","summary":"BRIEF-Elutia Inc May Offer & Sell Up To $50.0 Million Of Shares Of Class A Common Stock - SEC FilingApril 11  - Elutia Inc ELUT.O:ELUTIA INC MAY OFFER & SELL UP TO $50.0 MILLION OF SHARES OF CLASS A COMMON STOCK - SEC FILINGSource text: [ID:n0001104659-25-034215]Further company coverage: ELUT.O ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250411:nFWN3QP11C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ELUT","BK4139"],"gpt_icon":0},{"id":"2526646857","title":"Elutia Inc May Offer & Sell up to $50.0 Mln of Shares of Class a Common Stock - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2526646857","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526646857?lang=en_us&edition=fundamental","pubTime":"2025-04-12 04:22","pubTimestamp":1744402974,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250411:nFWN3QP11C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ELUT"],"gpt_icon":0},{"id":"2524445043","title":"Elutia to Debut EluPro™ at HRS 2025 — Experience the Difference Biology Makes","url":"https://stock-news.laohu8.com/highlight/detail?id=2524445043","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2524445043?lang=en_us&edition=fundamental","pubTime":"2025-04-03 04:05","pubTimestamp":1743624300,"startTime":"0","endTime":"0","summary":"Introduction of EluPro at HeartRhythm2025 in San Diego, April 25-27,2025. SILVER SPRING, Md., April 02, 2025  -- Elutia Inc.  , a pioneer in drug-eluting biomatrix products, is proud to announce the debut of its EluPro Antibiotic-Eluting BioEnvelope designed for cardiac implantable electronic devices  and neurostimulators at the Heart Rhythm Society’s annual meeting . Attendees will have the opportunity to experience firsthand the soft, conforming feel of EluPro and discover how its natural biomatrix supports healing while delivering trusted antibiotics to reduce bacterial colonization.Engineered for both performance and handling, EluPro features a proprietary biomatrix that drapes naturally around CIEDs, avoiding the rough, stiff feel often associated with synthetic alternatives. Combined with a trusted dual-antibiotic combination, EluPro offers physicians a solution designed for both efficacy and ease of use without compromise.“We are thrilled to introduce EluPro at HRS 2025 and give","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/elutia-debut-elupro-hrs-2025-200500045.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ELUT","BK4139"],"gpt_icon":0},{"id":"2522532500","title":"BRIEF-Elutia Announces GPO Agreement With Advantus Health Partners To Expand Access To EluPro","url":"https://stock-news.laohu8.com/highlight/detail?id=2522532500","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522532500?lang=en_us&edition=fundamental","pubTime":"2025-03-28 04:54","pubTimestamp":1743108871,"startTime":"0","endTime":"0","summary":"BRIEF-Elutia Announces GPO Agreement With Advantus Health Partners To Expand Access To EluProMarch 27 (Reuters) - Elutia Inc ELUT.O:ELUTIA ANNOUNCES GPO AGREEMENT WITH ADVANTUS HEALTH PARTNERS TO EXPA","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250327:nTUA1DRWW2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ELUT"],"gpt_icon":0},{"id":"2522938531","title":"Elutia announces GPO agreement with Advantus Health Partners","url":"https://stock-news.laohu8.com/highlight/detail?id=2522938531","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522938531?lang=en_us&edition=fundamental","pubTime":"2025-03-28 04:20","pubTimestamp":1743106834,"startTime":"0","endTime":"0","summary":"Elutia (ELUT) announced that it has entered into an agreement with Advantus Health Partners to provide access of Elutia’s EluPro Antibiotic Eluting...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/elutia-announces-gpo-agreement-with-advantus-health-partners?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/elutia-announces-gpo-agreement-with-advantus-health-partners?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ELUT","BK4139"],"gpt_icon":0},{"id":"2522539622","title":"Elutia Announces Gpo Agreement With Advantus Health Partners to Expand Access to Elupro™","url":"https://stock-news.laohu8.com/highlight/detail?id=2522539622","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522539622?lang=en_us&edition=fundamental","pubTime":"2025-03-28 04:05","pubTimestamp":1743105923,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250327:nTUA1DRWW2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ELUT"],"gpt_icon":0},{"id":"2522539478","title":"Press Release: Elutia Announces GPO Agreement with Advantus Health Partners to Expand Access to EluPro(TM)","url":"https://stock-news.laohu8.com/highlight/detail?id=2522539478","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522539478?lang=en_us&edition=fundamental","pubTime":"2025-03-28 04:05","pubTimestamp":1743105900,"startTime":"0","endTime":"0","summary":"SILVER SPRING, Md., March 27, 2025  -- Elutia Inc.  , a pioneer in drug-eluting biomatrix products, announced that it has entered into an agreement with Advantus Health Partners , to provide access of Elutia's EluPro Antibiotic Eluting BioEnvelope to Advantus' core group purchasing organizations  solutions portfolio.\"Teaming up with Advantus is another major step forward in meeting the strong customer demand for EluPro,\" said Dr. Kimberly Mulligan, GM and VP of Elutia's Cardiovascular Division. \"Our pilot launch of EluPro has exceeded our expectations as physicians recognize the unique value that this antibiotic envelope brings in preventing infection for patients that use a cardiac implantable electronic device. Broadening our GPO coverage with Advantus allows us to benefit from their sustainable contracting solutions, making EluPro more widely available to physicians nationwide.\"","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4604","BK4139","BK4099","TM","BK4588","03160","BK4555","BK4232","R","ELUT","BK4585","BK4022"],"gpt_icon":0},{"id":"2520642841","title":"BRIEF-Elutia Files For Mixed Shelf Of Up To $100 Million – SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2520642841","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520642841?lang=en_us&edition=fundamental","pubTime":"2025-03-18 18:23","pubTimestamp":1742293425,"startTime":"0","endTime":"0","summary":"BRIEF-Elutia Files For Mixed Shelf Of Up To $100 Million – SEC FilingMarch 18  - Elutia Inc ELUT.O:ELUTIA INC FILES FOR MIXED SHELF OF UP TO $100 MILLION – SEC FILINGELUTIA : SALES AGREEMENT PROSPECTUS COVERING ISSUANCE OF UP TO $50 MILLION OF CLASS A COMMON STOCK THAT MAY BE ISSUED UNDER SALES AGREEMENTSource text: [ID:n0001104659-25-024551]Further company coverage: ELUT.O ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250318:nFWN3Q01AH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ELUT"],"gpt_icon":0},{"id":"2520651644","title":"Elutia Inc Files for Mixed Shelf of up to $100 Mln – SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2520651644","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520651644?lang=en_us&edition=fundamental","pubTime":"2025-03-18 18:16","pubTimestamp":1742293003,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250318:nFWN3Q01AH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ELUT"],"gpt_icon":0},{"id":"2520644644","title":"Elutia : Sales Agreement Prospectus Covering Issuance of up to $50 Mln of Class a Common Stock That May Be Issued Under Sales Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2520644644","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520644644?lang=en_us&edition=fundamental","pubTime":"2025-03-18 18:16","pubTimestamp":1742293003,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250318:nFWN3Q01AH:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ELUT","BK4139"],"gpt_icon":0},{"id":"2517458273","title":"Elutia Price Target Maintained With a $8.00/Share by Cantor Fitzgerald","url":"https://stock-news.laohu8.com/highlight/detail?id=2517458273","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517458273?lang=en_us&edition=fundamental","pubTime":"2025-03-08 00:26","pubTimestamp":1741364760,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ELUT/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 07, 2025 11:26 ET (16:26 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ELUT"],"gpt_icon":0},{"id":"2517554435","title":"Analysts Offer Insights on Healthcare Companies: Phathom Pharmaceuticals (PHAT), Aziyo Biologics (ELUT) and IGM Biosciences (IGMS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2517554435","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517554435?lang=en_us&edition=fundamental","pubTime":"2025-03-07 21:51","pubTimestamp":1741355465,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Phathom Pharmaceuticals (PHAT – Research Report), Aziyo Biologics...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-phathom-pharmaceuticals-phat-aziyo-biologics-elut-and-igm-biosciences-igms?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-phathom-pharmaceuticals-phat-aziyo-biologics-elut-and-igm-biosciences-igms?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IGM","PHAT","IGMS","ELUT","BK4505","BK4139","BK4137","BK4007","HCSG"],"gpt_icon":0},{"id":"2517433352","title":"Q4 2024 Elutia Inc Earnings Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2517433352","media":"Thomson Reuters StreetEvents","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517433352?lang=en_us&edition=fundamental","pubTime":"2025-03-07 21:17","pubTimestamp":1741353431,"startTime":"0","endTime":"0","summary":"C. Randall Mills; President, Chief Executive Officer, Director; Elutia Inc. Frank Takkinen; Analyst; Lake Street Capital Markets LLC. Good afternoon, ladies and gentlemen. Welcome to the Elutia fourth quarter and full year 2024 financial results conference call.  Please be advised that today's conference call is being recorded. I would now like to hand the conference call over to David Carey, FINN Partners. Please go ahead.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/q4-2024-elutia-inc-earnings-131711097.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["MDT","ELUT","BSX"],"gpt_icon":0},{"id":"2517645172","title":"Elutia Inc (ELUT) Q4 2024 Earnings Call Highlights: Strategic Partnerships and Product Growth ...","url":"https://stock-news.laohu8.com/highlight/detail?id=2517645172","media":"GuruFocus.com","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517645172?lang=en_us&edition=fundamental","pubTime":"2025-03-07 15:15","pubTimestamp":1741331744,"startTime":"0","endTime":"0","summary":"BioEnvelope Sales: $2.7 million for the quarter, an 18% growth over the same quarter of the prior year.Full Year BioEnvelope Sales: $9.9 million, reflecting a 5% growth year-over-year.SimpliDerm Sales: $2.3 million for the quarter, down year-over-year; $11.6 million for the full year, up 12% year-over-year.Cardiovascular Sales: $0.5 million for the quarter, compared to $600,000 in the prior year quarter.Total Revenue: $5.5 million for the quarter, down 7% year-over-year; $24.4 million for the full year, down 1% from the prior year.Gross Margin: 43% for the quarter, up from 36% in the prior year; 58% excluding non-cash amortization, up from 51% in the prior year.Operating Expenses: $10.8 million for the quarter, consistent with $10.6 million in the prior year.Adjusted EBITDA: Loss of $3.8 million for the quarter, improved from a $4.5 million loss in the prior year.A: C. Randall Mills, President, CEO, and Director of Elutia Inc, explained that Elutia has an agreement with Boston Scientif","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/elutia-inc-elut-q4-2024-071544725.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BSX","ELUT"],"gpt_icon":0},{"id":"2517123407","title":"Elutia Inc. Reports Strong Demand for EluPro™","url":"https://stock-news.laohu8.com/highlight/detail?id=2517123407","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517123407?lang=en_us&edition=fundamental","pubTime":"2025-03-07 11:59","pubTimestamp":1741319982,"startTime":"0","endTime":"0","summary":"Aziyo Biologics, Inc. Class A ( ($ELUT) ) has released its Q4 earnings. Here is a breakdown of the information Aziyo Biologics, Inc. Class A presen...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/elutia-inc-reports-strong-demand-for-elupro?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/elutia-inc-reports-strong-demand-for-elupro?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","ELUT"],"gpt_icon":0},{"id":"2517111647","title":"Elutia Inc reports results for the quarter ended December 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2517111647","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517111647?lang=en_us&edition=fundamental","pubTime":"2025-03-07 06:01","pubTimestamp":1741298490,"startTime":"0","endTime":"0","summary":"Elutia Inc reports results for the quarter ended December 31 - Earnings SummaryElutia Inc ELUT.OQ reported a quarterly adjusted loss of 26 cents per share for the quarter ended December 31, higher tha","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250306:nL5N3PP2I4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ELUT"],"gpt_icon":0},{"id":"2517115426","title":"Elutia reports Q4 EPS (26c) vs. (40c) last year","url":"https://stock-news.laohu8.com/highlight/detail?id=2517115426","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517115426?lang=en_us&edition=fundamental","pubTime":"2025-03-07 05:32","pubTimestamp":1741296730,"startTime":"0","endTime":"0","summary":"Reports Q4 revenue $ $5.47M, consensus $5.9M.”Elutia (ELUT) closed out 2024 with the successful pilot launch of EluPro, the first ever FDA-cleared ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/elutia-reports-q4-eps-26c-vs-40c-last-year?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/elutia-reports-q4-eps-26c-vs-40c-last-year?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ELUT"],"gpt_icon":0},{"id":"2517811327","title":"Elutia Q4 GAAP EPS $(0.26) Misses $(0.25) Estimate, Sales $5.47M Miss $5.90M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2517811327","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517811327?lang=en_us&edition=fundamental","pubTime":"2025-03-07 05:18","pubTimestamp":1741295924,"startTime":"0","endTime":"0","summary":"Elutia (NASDAQ:ELUT) reported quarterly losses of $(0.26) per share which missed the analyst consensus estimate of $(0.25) by 4 percent. This is a 60.61 percent increase over losses of $(0.66) per share from the same","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/03/44179842/elutia-q4-gaap-eps-0-26-misses-0-25-estimate-sales-5-47m-miss-5-90m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Elutia Q4 GAAP EPS $(0.26) Misses $(0.25) Estimate, Sales $5.47M Miss $5.90M Estimate","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ELUT"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":52,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ELUT\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-03-06","symbol":"ELUT","fiscalQuarterEnding":"2024/12","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1741237200000,"reportTimeType":"post","actualEps":-0.26},{"market":"US","date":"2024-11-14","symbol":"ELUT","fiscalQuarterEnding":"2024/09","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1731560400000,"reportTimeType":"post","actualEps":-0.33},{"market":"US","date":"2024-08-07","symbol":"ELUT","fiscalQuarterEnding":"2024/06","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1723003200000,"reportTimeType":"post","actualEps":-1.14},{"market":"US","date":"2024-05-09","symbol":"ELUT","fiscalQuarterEnding":"2024/03","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1715227200000,"reportTimeType":"post","actualEps":-0.75},{"market":"US","date":"2024-03-07","symbol":"ELUT","fiscalQuarterEnding":"2023/12","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1709787600000,"reportTimeType":"post","actualEps":-0.66}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ELUT\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ELUT\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":2,"updateTime":1695960000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ELUT\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ELUT","date":"2025-04-17","current":-1.58571,"percent":0.793103,"low":-3.086243,"twenty":-2.39466,"median":-1.984722,"eighty":-1.546412,"high":-0.540943,"avg":-1.916841,"sd":0.539387,"marketCap":85547464},"quantilePoints":[{"date":"2023-09-15","current":-0.550518,"twenty":-0.608921,"median":-0.57924,"eighty":-0.548603,"marketCap":18687324},{"date":"2023-09-22","current":-0.732428,"twenty":-0.740087,"median":-0.598389,"eighty":-0.548603,"marketCap":24862265},{"date":"2023-09-29","current":-0.925604,"twenty":-0.854822,"median":-0.732428,"eighty":-0.573496,"marketCap":31419614},{"date":"2023-10-06","current":-0.877962,"twenty":-0.929687,"median":-0.810097,"eighty":-0.59073,"marketCap":29802428},{"date":"2023-10-13","current":-0.925604,"twenty":-0.925604,"median":-0.860947,"eighty":-0.599346,"marketCap":31419614},{"date":"2023-10-20","current":-0.89838,"twenty":-0.951466,"median":-0.884768,"eighty":-0.62041,"marketCap":30495508},{"date":"2023-10-27","current":-0.78268,"twenty":-0.946021,"median":-0.884768,"eighty":-0.631899,"marketCap":26568056},{"date":"2023-11-03","current":-0.911992,"twenty":-0.929687,"median":-0.884768,"eighty":-0.712322,"marketCap":30957561},{"date":"2023-11-10","current":-1.000469,"twenty":-0.959633,"median":-0.891574,"eighty":-0.763066,"marketCap":33960907},{"date":"2023-11-17","current":-1.104073,"twenty":-0.980051,"median":-0.89838,"eighty":-0.780289,"marketCap":37297800},{"date":"2023-11-24","current":-1.270365,"twenty":-0.999262,"median":-0.911992,"eighty":-0.786996,"marketCap":42915471},{"date":"2023-12-01","current":-1.256631,"twenty":-1.107415,"median":-0.925604,"eighty":-0.801891,"marketCap":42451520},{"date":"2023-12-08","current":-1.373368,"twenty":-1.121435,"median":-0.939215,"eighty":-0.813987,"marketCap":46395104},{"date":"2023-12-15","current":-1.359634,"twenty":-1.252511,"median":-0.959633,"eighty":-0.824876,"marketCap":45931152},{"date":"2023-12-22","current":-1.339033,"twenty":-1.319806,"median":-0.973245,"eighty":-0.842572,"marketCap":45235226},{"date":"2023-12-29","current":-1.45577,"twenty":-1.339033,"median":-0.980051,"eighty":-0.854822,"marketCap":49178810},{"date":"2024-01-05","current":-1.929581,"twenty":-1.359634,"median":-0.986857,"eighty":-0.867073,"marketCap":65185121},{"date":"2024-01-12","current":-2.217989,"twenty":-1.373368,"median":-1.000469,"eighty":-0.876601,"marketCap":74928092},{"date":"2024-01-19","current":-2.423994,"twenty":-1.431049,"median":-1.101384,"eighty":-0.882046,"marketCap":81887358},{"date":"2024-01-26","current":-2.746735,"twenty":-1.572506,"median":-1.114716,"eighty":-0.884768,"marketCap":92790208},{"date":"2024-02-02","current":-2.526996,"twenty":-1.981769,"median":-1.12197,"eighty":-0.888852,"marketCap":85366991},{"date":"2024-02-09","current":-2.544163,"twenty":-2.252323,"median":-1.229164,"eighty":-0.891574,"marketCap":85946930},{"date":"2024-02-16","current":-2.629999,"twenty":-2.386913,"median":-1.263498,"eighty":-0.895658,"marketCap":88846624},{"date":"2024-02-23","current":-2.307258,"twenty":-2.444594,"median":-1.290965,"eighty":-0.89838,"marketCap":77943774},{"date":"2024-03-01","current":-2.499529,"twenty":-2.444594,"median":-1.339033,"eighty":-0.901102,"marketCap":84439089},{"date":"2024-03-08","current":-2.465195,"twenty":-2.469315,"median":-1.352767,"eighty":-0.907908,"marketCap":83279211},{"date":"2024-03-15","current":-2.101428,"twenty":-2.462448,"median":-1.366501,"eighty":-0.914714,"marketCap":79131372},{"date":"2024-03-22","current":-2.062751,"twenty":-2.444594,"median":-1.373368,"eighty":-0.92152,"marketCap":77674966},{"date":"2024-03-28","current":-2.030521,"twenty":-2.423994,"median":-1.407702,"eighty":-0.925604,"marketCap":76461295},{"date":"2024-04-05","current":-1.991844,"twenty":-2.422621,"median":-1.469503,"eighty":-0.926965,"marketCap":75004889},{"date":"2024-04-12","current":-1.959549,"twenty":-2.40614,"median":-1.575939,"eighty":-0.933771,"marketCap":73788790},{"date":"2024-04-19","current":-1.96606,"twenty":-2.361505,"median":-1.8178,"eighty":-0.940576,"marketCap":74033952},{"date":"2024-04-26","current":-1.868793,"twenty":-2.353952,"median":-1.846646,"eighty":-0.948743,"marketCap":70371251},{"date":"2024-05-03","current":-1.810595,"twenty":-2.330605,"median":-1.843584,"eighty":-0.959633,"marketCap":68179759},{"date":"2024-05-10","current":-1.810595,"twenty":-2.314124,"median":-1.846646,"eighty":-0.960994,"marketCap":68179759},{"date":"2024-05-17","current":-1.644574,"twenty":-2.312751,"median":-1.842927,"eighty":-0.9678,"marketCap":78406723},{"date":"2024-05-24","current":-1.659896,"twenty":-2.304511,"median":-1.810595,"eighty":-0.974606,"marketCap":79137220},{"date":"2024-05-31","current":-1.644574,"twenty":-2.293524,"median":-1.794429,"eighty":-0.980051,"marketCap":78406723},{"date":"2024-06-07","current":-1.736507,"twenty":-2.272923,"median":-1.736507,"eighty":-0.980051,"marketCap":82789707},{"date":"2024-06-14","current":-1.976554,"twenty":-2.261937,"median":-1.746722,"eighty":-0.985496,"marketCap":94234167},{"date":"2024-06-21","current":-2.009118,"twenty":-2.238589,"median":-1.746722,"eighty":-0.993817,"marketCap":95786700},{"date":"2024-06-28","current":-2.447891,"twenty":-2.25919,"median":-1.772259,"eighty":-0.998457,"marketCap":116705635},{"date":"2024-07-05","current":-2.528717,"twenty":-2.308631,"median":-1.797662,"eighty":-1.000067,"marketCap":120559123},{"date":"2024-07-12","current":-2.644184,"twenty":-2.359446,"median":-1.814198,"eighty":-1.000469,"marketCap":126064106},{"date":"2024-07-15","current":-2.540264,"twenty":-2.362192,"median":-1.8178,"eighty":-1.000469,"marketCap":121109621},{"date":"2024-08-02","current":-1.974478,"twenty":-2.361505,"median":-1.830364,"eighty":-1.020114,"marketCap":94135205},{"date":"2024-08-09","current":-1.29534,"twenty":-2.353952,"median":-1.810595,"eighty":-1.09977,"marketCap":84501485},{"date":"2024-08-16","current":-1.754315,"twenty":-2.330605,"median":-1.781728,"eighty":-1.105744,"marketCap":114442745},{"date":"2024-08-23","current":-2.093692,"twenty":-2.314124,"median":-1.810595,"eighty":-1.112886,"marketCap":136581967},{"date":"2024-08-30","current":-2.140682,"twenty":-2.312751,"median":-1.830364,"eighty":-1.115007,"marketCap":139647398},{"date":"2024-09-06","current":-2.109355,"twenty":-2.307258,"median":-1.845034,"eighty":-1.116169,"marketCap":137603777},{"date":"2024-09-13","current":-2.271212,"twenty":-2.293524,"median":-1.853208,"eighty":-1.119295,"marketCap":148162483},{"date":"2024-09-20","current":-1.99971,"twenty":-2.272923,"median":-1.868793,"eighty":-1.124646,"marketCap":130451106},{"date":"2024-09-27","current":-2.04148,"twenty":-2.271212,"median":-1.875815,"eighty":-1.198295,"marketCap":133175933},{"date":"2024-10-04","current":-1.989268,"twenty":-2.26599,"median":-1.888192,"eighty":-1.198295,"marketCap":129769899},{"date":"2024-10-11","current":-1.957941,"twenty":-2.25919,"median":-1.894658,"eighty":-1.201697,"marketCap":127726278},{"date":"2024-10-18","current":-1.871792,"twenty":-2.245106,"median":-1.91272,"eighty":-1.229164,"marketCap":122106322},{"date":"2024-10-25","current":-1.68644,"twenty":-2.224855,"median":-1.894658,"eighty":-1.249764,"marketCap":110014901},{"date":"2024-10-31","current":-1.655113,"twenty":-2.224348,"median":-1.888192,"eighty":-1.255258,"marketCap":107971280},{"date":"2024-11-08","current":-1.978826,"twenty":-2.219235,"median":-1.891425,"eighty":-1.263969,"marketCap":129088692},{"date":"2024-11-15","current":-1.99971,"twenty":-2.191779,"median":-1.91095,"eighty":-1.269453,"marketCap":130451106},{"date":"2024-11-22","current":-2.764944,"twenty":-2.238694,"median":-1.926614,"eighty":-1.270365,"marketCap":149865500},{"date":"2024-11-29","current":-2.639886,"twenty":-2.266998,"median":-1.927383,"eighty":-1.284312,"marketCap":143087085},{"date":"2024-12-06","current":-2.748287,"twenty":-2.299018,"median":-1.929581,"eighty":-1.294648,"marketCap":148962642},{"date":"2024-12-13","current":-2.525108,"twenty":-2.344339,"median":-1.940802,"eighty":-1.305076,"marketCap":136865908},{"date":"2024-12-20","current":-2.250917,"twenty":-2.413049,"median":-1.95272,"eighty":-1.323927,"marketCap":122004205},{"date":"2024-12-27","current":-2.646262,"twenty":-2.438332,"median":-1.956124,"eighty":-1.334913,"marketCap":143432706},{"date":"2025-01-03","current":-2.168022,"twenty":-2.456241,"median":-1.957941,"eighty":-1.339033,"marketCap":117511133},{"date":"2025-01-10","current":-2.168022,"twenty":-2.447891,"median":-1.959614,"eighty":-1.339033,"marketCap":117511133},{"date":"2025-01-17","current":-2.046868,"twenty":-2.423994,"median":-1.970269,"eighty":-1.3459,"marketCap":110944334},{"date":"2025-01-24","current":-2.091504,"twenty":-2.423994,"median":-1.97769,"eighty":-1.356887,"marketCap":113363681},{"date":"2025-01-31","current":-1.976726,"twenty":-2.4185,"median":-1.976554,"eighty":-1.359634,"marketCap":107142503},{"date":"2025-02-07","current":-1.937476,"twenty":-2.411689,"median":-1.970269,"eighty":-1.365128,"marketCap":105015096},{"date":"2025-02-14","current":-2.114955,"twenty":-2.389925,"median":-1.974478,"eighty":-1.371995,"marketCap":114634800},{"date":"2025-02-21","current":-2.366383,"twenty":-2.395026,"median":-1.976726,"eighty":-1.373368,"marketCap":128262713},{"date":"2025-02-28","current":-2.329409,"twenty":-2.395026,"median":-1.980336,"eighty":-1.373368,"marketCap":126258608},{"date":"2025-03-07","current":-1.885712,"twenty":-2.395026,"median":-1.984047,"eighty":-1.389848,"marketCap":102209349},{"date":"2025-03-14","current":-2.414629,"twenty":-2.395026,"median":-1.984047,"eighty":-1.409075,"marketCap":130266818},{"date":"2025-03-21","current":-2.446524,"twenty":-2.415305,"median":-1.989268,"eighty":-1.43929,"marketCap":131987517},{"date":"2025-03-28","current":-2.008566,"twenty":-2.412303,"median":-1.989268,"eighty":-1.46401,"marketCap":108360122},{"date":"2025-04-04","current":-2.197341,"twenty":-2.410499,"median":-1.989268,"eighty":-1.510704,"marketCap":118544344},{"date":"2025-04-11","current":-1.691424,"twenty":-2.404863,"median":-1.989268,"eighty":-1.550532,"marketCap":91250629},{"date":"2025-04-17","current":-1.58571,"twenty":-2.39466,"median":-1.984722,"eighty":-1.546412,"marketCap":85547464}],"updateTime":1745261537778}}}